OneMedNet Corp (ONMD): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$2.96M
As of 2025-12-31
-$3.52M
As of 2026-06-30
2021-12-31: -$8.61M2022-12-31: -$26.36M2023-12-31: -$13.44M2024-12-31: -$15.95M2025-12-31: -$2.96M-$2.96M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$2.96Mn/m2026-03-30, Balance as of period end
2024-12-31-$15.95Mn/m2026-03-30, Balance as of period end
2023-12-31-$13.44Mn/m2025-04-15, Balance as of period end
2022-12-31-$26.36Mn/c2024-11-05, Balance as of period end
2021-12-31-$8.61Mn/a2023-03-31, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
OneMedNet Corp (ONMD)2025-12-31-$2.96Mn/m
iSpecimen Inc. (ISPC)2025-12-31$3.09M-6.7%
Absci Corp (ABSI)2025-12-31$189.45M+5.8%
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$1.16Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31$7.28M+179.7%
Foxo Technologies Inc. (FOXO)2025-12-31$11.14M+109.3%
OmniAb, Inc. (OABI)2025-12-31$267.03M-7.2%
MaxCyte, Inc. (MXCT)2025-12-31$171.49M-16.9%
NRC Health (NRC)2025-12-31$13.99M-55.3%

Compare ONMD, ISPC, ABSI, CBIH side by side · Screen every company in Services-Commercial Physical & Biological Research ↗